Es gab 50 kürzliche Insider-Transaktionen für Third Harmonic Bio, Inc. (THRD), darunter 27 Käufe und 19 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $28.37M und die gesamten Insider-Verkäufe auf $2.72M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Murphy Christopher M., Holles Natalie C., Conner Edward R.. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — THRD
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2025-03-01 |
Murphy Christopher M. |
Chief Financial & Bus. Officer |
RSU-Zuteilung |
30,000 |
- |
- |
30,000 |
| 2025-01-15 |
Holles Natalie C. |
CEO |
RSU-Zuteilung |
50,000 |
- |
- |
50,000 |
| 2025-01-15 |
Conner Edward R. |
Chief Medical Officer |
RSU-Zuteilung |
16,500 |
- |
- |
16,500 |
| 2025-01-15 |
Dinsmore Christopher |
Chief Scientific Officer |
RSU-Zuteilung |
14,500 |
- |
- |
14,500 |
| 2025-01-15 |
Person Julie |
Chief Administrative Officer |
RSU-Zuteilung |
12,500 |
- |
- |
12,500 |
| 2025-01-15 |
Murphy Christopher M. |
Chief Financial & Bus. Officer |
RSU-Zuteilung |
17,500 |
- |
- |
17,500 |
| 2025-01-15 |
Dittman Jennifer |
Chief Operating Officer |
RSU-Zuteilung |
11,500 |
- |
- |
11,500 |
| 2025-01-15 |
Dean Dennis |
Chief Nonclinical Dev. Officer |
RSU-Zuteilung |
11,500 |
- |
- |
11,500 |
| 2024-11-08 |
Conner Edward R. |
Chief Medical Officer |
Informierter Verkauf |
2,117 |
$15.00 |
$31.76K |
- |
| 2024-11-01 |
Atlas Venture Fund Xi, L.p. |
10 Percent Owner |
Sonstige (Verkauf) |
515,688 |
- |
- |
9,798,075 |
| 2024-10-29 |
Bvf Partners L P/il |
Other: See Explanation of Responses |
Informierter Verkauf |
64,617 |
$14.30 |
$924.02K |
176,692 |
| 2024-10-28 |
Conner Edward R. |
Chief Medical Officer |
Informierter Verkauf |
2,673 |
$15.00 |
$40.1K |
- |
| 2024-09-19 |
Conner Edward R. |
Chief Medical Officer |
Informierter Verkauf |
4,790 |
$15.00 |
$71.85K |
- |
| 2024-09-19 |
Person Julie |
Chief Administrative Officer |
Informierter Verkauf |
9,497 |
$14.29 |
$135.68K |
- |
| 2024-09-18 |
Person Julie |
Chief Administrative Officer |
Informierter Verkauf |
503 |
$14.00 |
$7.04K |
- |
| 2024-06-26 |
Person Julie |
Chief Administrative Officer |
Informierter Verkauf |
10,000 |
$12.46 |
$124.57K |
- |
| 2024-06-07 |
Dittman Jennifer |
Chief Development Oper Officer |
Informierter Verkauf |
494 |
$14.17 |
$7K |
- |
| 2024-06-06 |
Iwicki Mark T |
Director |
RSU-Zuteilung |
20,000 |
$13.85 |
$277K |
20,000 |
| 2024-06-06 |
Soloway Thomas P |
Director |
RSU-Zuteilung |
20,000 |
$13.85 |
$277K |
20,000 |
| 2024-06-06 |
Bonita David P |
Director |
RSU-Zuteilung |
20,000 |
$13.85 |
$277K |
20,000 |
| 2024-06-06 |
Gladstone Michael |
10 Percent Owner |
RSU-Zuteilung |
20,000 |
$13.85 |
$277K |
20,000 |
| 2024-06-06 |
Seidel Hans Martin |
Director |
RSU-Zuteilung |
20,000 |
$13.85 |
$277K |
20,000 |
| 2024-05-20 |
Dittman Jennifer |
Chief Development Oper Officer |
Informierter Verkauf |
1,042 |
$14.00 |
$14.59K |
- |
| 2024-05-16 |
Dinsmore Christopher |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-05-16 |
Dinsmore Christopher |
Chief Scientific Officer |
RSU-Zuteilung |
210,000 |
$14.23 |
$2.99M |
210,000 |
| 2024-05-16 |
Dittman Jennifer |
Chief Development Oper Officer |
Veräußerung |
50,000 |
$4.30 |
$215K |
- |
| 2024-05-16 |
Dittman Jennifer |
Chief Development Oper Officer |
Informierter Verkauf |
23,578 |
$14.04 |
$331.07K |
- |
| 2024-05-16 |
Dean Dennis |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-05-16 |
Dean Dennis |
Chief Nonclinical Dev. Officer |
RSU-Zuteilung |
210,000 |
$14.23 |
$2.99M |
210,000 |
| 2024-05-16 |
Dinsmore Christopher |
Chief Scientific Officer |
RSU-Zuteilung |
297,000 |
$14.23 |
$4.23M |
297,000 |
| 2024-05-09 |
Holles Natalie C. |
CEO |
Optionsausübung (Verkauf) |
20,222 |
$4.20 |
$84.93K |
433,854 |
| 2024-04-11 |
Holles Natalie C. |
CEO |
Optionsausübung (Verkauf) |
13,558 |
$4.20 |
$56.94K |
454,076 |
| 2024-04-04 |
Person Julie |
Chief Administrative Officer |
Informierter Verkauf |
1,107 |
$10.00 |
$11.07K |
- |
| 2024-03-27 |
Mcdonough Geoff |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-03-27 |
Mcdonough Geoff |
Director |
RSU-Zuteilung |
60,000 |
$9.47 |
$568.2K |
60,000 |
| 2024-01-05 |
Holles Natalie C. |
CEO |
RSU-Zuteilung |
396,000 |
$10.89 |
$4.31M |
396,000 |
| 2024-01-05 |
Holles Natalie C. |
CEO |
RSU-Zuteilung |
396,000 |
$10.89 |
$4.31M |
396,000 |
| 2024-01-05 |
Conner Edward R. |
Chief Medical Officer |
RSU-Zuteilung |
133,000 |
$10.89 |
$1.45M |
133,000 |
| 2024-01-05 |
Person Julie |
Chief Administrative Officer |
RSU-Zuteilung |
116,000 |
$10.89 |
$1.26M |
116,000 |
| 2024-01-05 |
Murphy Christopher M. |
Chief Financial & Bus. Officer |
RSU-Zuteilung |
410,000 |
$10.89 |
$4.46M |
410,000 |
| 2024-01-04 |
Murphy Christopher M. |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2023-12-05 |
Conner Edward R. |
Chief Medical Officer |
Informierter Verkauf |
4,790 |
$10.03 |
$48.06K |
- |
| 2023-12-05 |
Person Julie |
Chief Administrative Officer |
Informierter Verkauf |
12,863 |
$10.30 |
$132.48K |
- |
| 2023-06-06 |
Iwicki Mark T |
Director |
RSU-Zuteilung |
16,250 |
$5.03 |
$81.74K |
16,250 |
| 2023-06-06 |
Soloway Thomas P |
Director |
RSU-Zuteilung |
16,250 |
$5.03 |
$81.74K |
16,250 |
| 2023-06-06 |
Bonita David P |
10 Percent Owner |
RSU-Zuteilung |
16,250 |
$5.03 |
$81.74K |
16,250 |
| 2023-06-06 |
Gladstone Michael |
Director |
RSU-Zuteilung |
16,250 |
$5.03 |
$81.74K |
16,250 |
| 2023-06-06 |
Seidel Hans Martin |
Director |
RSU-Zuteilung |
16,250 |
$5.03 |
$81.74K |
16,250 |
| 2023-03-06 |
Perez Robert J |
Director |
Aktienrückgabe |
13,667 |
$17.83 |
$243.68K |
- |
| 2023-03-06 |
Iwicki Mark T |
Director |
Aktienrückgabe |
13,667 |
$17.83 |
$243.68K |
- |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
